A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a "masked T-cell engager". This type of immunotherapy ignites our own ...

EAU26: prostate cancer screening compares favourably compared to breast cancer in identifying significant cancers and reducing mortality.

Pfizer Inc. (NYSE:PFE) announced that its Phase 3 TALAPRO-3 clinical trial met its primary endpoint, demonstrating that the ...

AI-assisted imaging improved prostate cancer diagnosis and biopsy decision-making in new research presented at EAU 2026.

Apalutamide in patients with metastatic hormone-sensitive prostate cancer: Real-world experience and a retrospective multicenter analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...

Prostate cancer screening saves many more lives than earlier studies suggested, research shows. The results from the longest-running European trial show one life saved for every six men diagnosed, a ...

A prostate cancer committee has been accused of exaggerating the risks of screening. Advisers to Wes Streeting, the Health Secretary, rejected calls to offer targeted testing in November, arguing that ...

A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced prostate cancer, according to a phase II clinical trial conducted at Kurume ...

The Prostate Cancer Foundation (PCF) today announced the recipients of its 2025 Challenge Awards, providing over $12 million in funding for 12 multi-institutional, cross-disciplinary research teams ...

If you're facing a prostate cancer diagnosis, this guide to best dietary practices will help simplify your shopping list Getty What you eat can affect your prostate health, for better or worse.